UnitedHealth’s Earnings Recovery Hides Lingering Risks
UnitedHealth Group (UNH) reported better-than-expected second-quarter earnings of $6.38 per share, surpassing analyst estimates and raising its full-year outlook to between $19.50 and $20 per share. The company also improved its medical loss ratio from 89.4% a year earlier to 86.7%, indicating better control over healthcare costs. This improvement was partly due to favorable prior-period adjustments, which may not be sustainable long-term. Despite the positive earnings report and strong performance in Optum’s health services unit, UnitedHealth continues to face federal scrutiny of its Medicare billing practices. Management also warned that medical cost trends remain high, particularly for specialty pharmaceuticals and under the No Surprises Act. These factors raise concerns about whether the recent financial improvements are structural or temporary. Investors like Steve Weiss have continued buying shares, while billionaire Bill Ackman has expressed caution over potential deeper issues.
Tickers: $UNH
Topics: earnings government probes healthcare medical costs UnitedHealth Group